Table 4.

Univariable and Multivariable Cox Proportional Hazards Model Analysis of Adverse Event (n=161)

	Univariable		Multivariable
	Hazard ratio (95% CI)	P value	Hazard ratio (95% CI)	P value
Age	1.02 (0.99–1.05)	0.26
Female sex	0.69 (0.30–1.57)	0.37
LV ejection fraction<50%	2.63 (1.08–6.37)	0.033	2.20 (0.89–5.41)	0.088
LV geometrical abnormality	1.73 (0.76–3.95)	0.20
LV wall motion abnormality	8.59 (1.16–63.60)	0.04
Isolated CS by JCS criteria	2.82 (1.16–6.83)	0.022	3.35 (1.08–10.39)	0.036
CS by JCS criteria	0.54 (0.16–1.82)	0.32
CS or isolated CS by JCS criteria	1.41 (0.63–3.18)	0.41
CS by Heart Rhythm Society criteria	0.39 (0.05–2.92)	0.36
CS by Japanese Ministry of Health and Welfare criteria	0.93 (0.28–3.11)	0.90
18F‐fluorodeoxyglucose positron emission tomography positive findings	1.43 (0.63–3.21)	0.39
Presence of late gadolinium enhancement on cardiac magnetic resonance imaging	0.99 (0.44–2.28)	0.99
Steroid therapy	0.98 (0.42–2.29)	0.96	0.56 (0.19–1.65)	0.30

CS indicates cardiac sarcoidosis; JCS, Japanese Circulation Society; and LV, left ventricular.